Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells

British Journal of Pharmacology

Volumn 127, Issue 1, 1999, Pages 75-84

  Condorelli, Fabrizio ^a   Canonico, Pier Luigi ^b   Sortino, Maria Angela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE

Author keywords

Acidic sphingomyelinase; Apoptosis; Cell cycle; IL 1 ; Neutral sphingomyelinase; Prostrate; TNF

Indexed keywords

BISBENZIMIDE; CERAMIDE; INTERLEUKIN 1BETA; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

EID: 0032956442     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702507     Document Type: Article

References (39)

1. Agresti, C.D., Urso, D. & Levi, G. (1996). Reversible inhibitory effect of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentation in vitro. Eur. J. Neurosci., 8, 1106-1116.
2. Bielawska, A., Crane, H.M., Liotta, D., Obeid, L.M. & Hannun Y.A. (1993). Selectivity of ceramide-mediated biology. J. Biol. Chem., 268, 26226-26232.
3. 1. Endocrinology, 138, 1491-1497.
4. Cobb, R.R., Felts, K.A., Parry, G.C.N. & Mackman, N. (1996). D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-Iβ-induced vascular cell endothelial molecule 1 gene expression in human endothelial cells. Mol. Pharmacol., 49, 998-1004.
5. Copani, A., Bruno, V.M., Barresi, V., Battaglia, G., Condorelli, D.F. & Nicoletti, F. (1995). Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. J. Neurochem., 64, 101-108.
6. Dobrowsky, R.T., Werner, M.H., Castellino, A.M., Chao, M.V. & Hannun, Y.A. (1994). Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science, 265, 1596-1599.
7. Fruehauf, J.P., Myers, C.E. & Sinha, B.K. (1990). Synergistic activity of suramin with tumor necrosis factor-α and doxorubicin on human prostate cancer cell lines. J. Natl. Cancer Inst., 82, 1206-1209.
8. Goodman, Y. & Mattson, M.P. (1996). Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem., 66, 869-872.
9. Hannun, Y.A. (1994). The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269, 3125-3128.
10. Hebestreit, H., Dibbert, B., Balati, I., Braun, D., Schapowal, A., Blaser, K. & Simon, H.U. (1998). Disruption of fas receptor signaling by nitric oxide in eosinophils. J. Exp. Med., 187, 415-425.
11. Hermann, J.L., Menter, D.G., Beham, A., Von Eschenbach, A., McDonnel, T.J. (1997). Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp. Cell Res., 24, 442-451.
12. Horoszewicz, J.S., Leong, S.S., Kawinski, E., Karr, J.P., Rosenthal, H., Chu, T.M., Mirand, E.A. & Murphy, G.P. (1983). LNCaP model of human prostatic carcinoma. Cancer Res., 43, 1809-1818.
13. Ito, A. & Horigome, K. (1995). Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J. Neurochem., 65, 463-466.
14. Jarvis, W.D, Kolesnick, R.N, Fornari, F.A, Traylor, R.S, Gewirtz, D.A. & Grant, S. (1994). Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. U.S.A., 91, 73-77.
15. Jayadev, S., Liu, B., Bielawska, A.E., Lee, J.Y., Nazaire, F., Pushkareva, M.Y., Obeid, L.M. & Hannun, Y.A. (1995). Role for ceramide in cell cycle arrest. J. Biol. Chem., 270, 2047-2052.
16. Kemick, M.S., Wang, D. & Lin, T. (1996). Interleukin-1 inhibits the proliferation of the human prostate cancer line LNCaP. Program of the 10th International Congress of Endocrinology, San Francisco, 1996, PI 84 (Abstract).
17. Kim, M.Y., Linardic, C., Obeid, L. & Hannun, Y.A. (1991). Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon. Specific role in cell differentiation. J. Biol. Chem., 266, 484-489.
18. 3 pituitary cells. J. Biol. Chem., 262, 16759-16762.
19. Kolesnick, R. & Golde, D.W. (1994). The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 77, 325-328.
20. Krishan, A. (1975). Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66, 188-193.
21. Masamune, A., Igarashi, Y. & Hakamori, S. (1996). Regulatory role of ceramide in interleukin (IL)-1/β-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1/β action, but is not sufficient for E-selectin expression. J. Biol. Chem., 271, 9368-9375.
22. Mathias, S., Younes, A., Kan, C.-C., Orlow, I., Joseph, C. & Kolesnick, R.N. (1993). Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science, 259, 519-522.
23. Nakajima, Y., Dellipizzi, A., Mallouh, C. & Ferreri, N.R. (1995). Effects of tumor necrosis factor-α and interferon-γ on the growth of human prostate cancer cell lines. Urol. Res., 23, 205-210.
24. Obeid, L.M, Linardic, C.M., Karolak, L.A. & Hannun, Y.A. (1993). Programmed cell death induced by ceramide. Science, 259, 1769-1771.
25. 3 in HL-60 cells. J. Biol. Chem., 264, 19076-19080.
26. 3-induced HL-60 cell differentiation. J. Biol. Chem., 265, 15823-15831.
27. Olivera, A., Buckley, N.E. & Spiegel, S. (1992). Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem., 267, 26121-26127.
28. Preiss, J., Loomis, C.R., Bishop, W.R., Stein, R., Niedel, J.E. & Bell, R.M. (1986). Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras-and sistransformed normal rat kidney cels. J. Biol. Chem., 261, 8597-8600.
29. Pushkareva, M., Obeid, L.M. & Hannun, Y.A. (1995). Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today, 16, 294-297.
30. Ritchie, C.K., Andrews, L.R., Thomas, K.G., Tindall, D.J., Fitzpatrick, L.A. (1997). The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease. Endocrinology, 138, 1145-1150.
31. Santana, P., Llanes, L., Hernandez, I., Gonzales-Robayna, I., Tabraue, C., Gonzales-Reyes, J., Quintana, J., Estevez, F., Ruiz De Galarreta, C.M. & Fanjul, L.F. (1996). Interleukin-1/β stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis. Endocrinology, 137, 2480-2489.
32. Sherwood, E.R., Ford, T.R., Lee, C. & Kozlowski, J.M. (1990). Therapeutic efficacy of recombinant tumor necrosis factor alpha in an experimental model of human prostatic carcinoma. J. Biol. Response Modif., 9, 44-52.
33. 3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132, 1952-1960.
34. Smith, C.A., Farrah, T. & Goodwin, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76, 959-962.
35. Sokoloff, M.H., Tso, C.-L., Kaboo, R., Taneja, S., Pang, S., Dekernion, J.B. & Belldegrun, A.S. (1996). In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer, 77, 1862-1872.
36. Testi, R. (1996). Sphingomyelin breakdown and cell fate. Trends Biol. Sci., 21, 468-471.
37. Van Moorselaar, R.J., Van Stratum, P., Borm, G., Debruyne, M. & Schalken, J.A. (1991). Differential antiproliferative activities of α-and γ-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice. Prostate, 8, 331-344.
38. Wertz. I.E. & Hanley, M.R. (1996). Diverse molecular provocation of programmed cell death. Trends Biol. Sci., 21, 359-364.
39. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D. & Kronke, M. (1994). Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell, 78, 1005-1015.